Pfizer hopes to keep 40 percent of Lipitor users through May, six months after the drug’s patent protection expires.
(Matt Rourke/Associated Press/file)
Pfizer strikes deals to hold on to Lipitor market share
Cholesterol drug’s patent expires at end of November
Pfizer hopes to keep 40 percent of Lipitor users through May, six months after the drug’s patent protection expires.
(Matt Rourke/Associated Press/file)
Pfizer Inc. is seeking to add Express Scripts Inc. to the list of U.S. pharmacy benefits managers that won’t dispense generic Lipitor after the world’s best-selling drug loses patent protection this month.
For more from BostonGlobe.com, sign up or log in below
To continue, please sign up or log in to BostonGlobe.com
Access the full articles and quality reporting of The Boston Globe at BostonGlobe.com
Sign up
Unlimited Access to BostonGlobe.com for 4 weeks for only 99¢.
Are you a Boston Globe home delivery subscriber?
Get FREE access as part of your print subscription.
BostonGlobe.com subscriber
Click to continue reading this article or to log in to BostonGlobe.com.
